With over 18 years of experience in Quality and Operations roles, Peter Kim is presently serving as the Senior Director of Quality at PCI Pharma Services, a world leading CDMO. Before taking on his current role in 2023, he held the position of Head of Quality for Aprogen Biologics (South Korea CDMO) and served as the Operations Part Leader for Aseptic Fill Finish at Samsung Biologics. In these roles, he successfully led remediation efforts for worldwide approval and implemented Operation Excellence initiatives to drive organizational profit. Prior to that, Peter held Manufacturing and Quality roles with increasing responsibility at Pacira Pharmaceuticals, Dendreon, and Taekda (formerly Baxter Bioscience). He earned his B.A. degree in Biology from the University of California, Berkeley.